GlassScriptPhysician profile
George Mcclellan Dimeling
NPI 1932398161
$8,870.19
in general payments reported to CMS, 2019-2025
22 companies · $2,897 in 2025
The $2,897 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,192 · 2020: $168 · 2021: $562 · 2022: $395 · 2023: $580 · 2024: $1,077 · 2025: $2,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,574 · Travel and Lodging: $1,960 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,573.56 |
| Travel and Lodging | $1,959.91 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,972.86 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Atricure, INC. | $1,402.79 | 2020-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Bolton Medical INC | $1,345.89 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $766.81 | 2021-2025 | Konect Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Medtronic, INC. | $582.13 | 2021-2024 | Penditure, Avalus |
| Silk Road Medical, INC. | $273.27 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abiomed | $117.10 | 2025 | |
| Getinge USA Sales, LLC | $80.92 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Corcym INC | $47.88 | 2023 | Perceval |
| Abbott Laboratories | $36.60 | 2023 | Epic |
| Stryker Corporation | $35.80 | 2024 | Na |
| Medtronic Vascular, INC. | $26.56 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $25.22 | 2024 | Arcalyst |
| Boston Scientific Corporation | $20.43 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.63 | 2025 | |
| Solventum Corporation | $18.55 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Kls-Martin L.P. | $18.54 | 2025 | |
| Baxter Healthcare | $17.81 | 2025 | Coseal |
| Livanova USA, INC. | $16.01 | 2022 | |
| Medistim USA, INC. | $14.71 | 2021 | |
| Lsi Solutions INC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Dimeling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.